IP Verse

Drospirenon (6Ss, 7Ss; 15Ss,16Ss-Dimethylene-3-Oxo-17Alpha-Pregn-4-Ene-21,17-Carbolactone, Drsp) With Less Than 0.2 % Impurity

Patent No. EP2168974 (titled "Drospirenon (6Ss, 7Ss; 15Ss,16Ss-Dimethylene-3-Oxo-17Alpha-Pregn-4-Ene-21,17-Carbolactone, Drsp) With Less Than 0.2 % Impurity") was filed by Bayer on Aug 11, 1997. The application was issued on Jul 2, 2014.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GENERICS UK TRADING MYLANApr 2, 2015JOHNSON
LABORATORIOS LEON FARMANov 7, 2014SCHON
TEVA PHARMACEUTICAL INDUSTRIES LTDOct 2, 2014FRIEDRICH, RAINER
INDUSTRIALE CHIMICA S.R.L.Jul 7, 2014PALLADINO
HEXALJul 7, 2014TER MEER UND PARTNER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP2168974

BAYER
Application Number
EP09100011A
Filing Date
Aug 11, 1997
Status
Revoked
Oct 19, 2018
Publication Date
Jul 2, 2014
External Links
Slate, Register , Google Patents